✦ LIBER ✦

E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion

✍ Scribed by Hilary Glen; Susan Mason; Hitesh Patel; Kenneth Macleod; Valerie G Brunton

Book ID: 115010366
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 838 KB
Volume: 11
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-11-309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor activities of the targeted mul

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

✍ Okamoto, Kiyoshi; Kodama, Kotaro; Takase, Kazuma; Sugi, Naoko Hata; Yamamoto, Yu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 568 KB

E7080, a Multi-Tyrosine Kinase Inhibitor

E7080, a Multi-Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles

✍ Ikuta, K.; Yano, S.; Trung, V. T.; Hanibuchi, M.; Goto, H.; Li, Q.; Wang, W.; Ya 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 598 KB

146 E7080, a novel multi-targeted tyrosi

146 E7080, a novel multi-targeted tyrosine kinase inhibitor, exhibits anti-angiogenic activity via inhibition of KIT signalling in a small cell lung cancer xenograft model

✍ J. Matsui; Y. Yamamoto; K. Miyazaki; A. Tsuruoka; T. Watanabe; M. Okada; S. Abe; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

A phase 1b clinical trial of the multi-t

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

✍ Molina, Ana M.; Hutson, Thomas E.; Larkin, James; Gold, Anne M.; Wood, Karen; Ca 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 395 KB

A Novel EPAC-Specific Inhibitor Suppress

A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and Invasion

✍ Almahariq, M.; Tsalkova, T.; Mei, F. C.; Chen, H.; Zhou, J.; Sastry, S. K.; Schw 📂 Article 📅 2012 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 860 KB

Topical administration of a multi-target

Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema

✍ John Doukas; Sankaranarayana Mahesh; Naoyasu Umeda; Shu Kachi; Hideo Akiyama; Ka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

## Abstract Age‐related macular degeneration, diabetic retinopathy, and retinal vein occlusions are complicated by neovascularization and macular edema. Multi‐targeted kinase inhibitors that inhibit select growth factor receptor tyrosine kinases and/or components of their down‐stream signaling casc